PD Dr. med. Sermin Toto

continue to the curriculum vitae

Schneider M, Pauwels P, Toto S, Bleich S, Grohmann R, Heinze M, Greiner T.

Severe weight gain as an adverse drug reaction of psychotropics: Data from the AMSP project between 2001 and 2016.

Eur Neuropsychopharmacol. 2020 Jun 11:S0924-977X(20)30130-9. doi: 10.1016/j.euroneuro.2020.05.001. Online ahead of print.

Hefner G, Wolff J, Hahn M, Hiemke C, Toto S, Roll SC, Messer T, Klimke A.

Prevalence and sort of pharmacokinetic drug-drug interactions in hospitalized psychiatric patients.

J Neural Transm (Vienna). 2020 Jun 9. doi: 10.1007/s00702-020-02214-x. Online ahead of print.

Seifert J, Heck J, Eckermann G, Singer M, Bleich S, Grohmann R, Toto S.

Psychopharmacotherapy during the COVID-19 pandemic

Neurologist. 2020 Jun 2:1-7. doi: 10.1007/s00115-020-00939-4. Online ahead of print.

Friedrich M-E, Winkler D, Konstantindis A, Huf W, Engel R, Toto S, Grohmann R, Kasper S.

Cardiovascular adverse reactions during antipsychotic treatment: Results of AMSP- A drug surveillance program between 1993 and 2013

Int J Neuropsychopharmacol. 2019 Aug 30. pii: pyz046. doi: 10.1093/ijnp/pyz046. [Epub ahead of print]

Druschky K, Bleich S, Grohmann R, Engel RR, Toto S, Neyazi A, Däubl B, Stübner S.

Severe parkinsonism under treatment with antipsychotic drugs.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug 23. doi: 10.1007/s00406-019-01060-7. [Epub ahead of print]

Greiner T, Haack B, Toto S, Bleich S, Grohmann R, Faltraco F, Heinze M, Schneider M.

Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016.

Eur Arch Psychiatry Clin Neurosci. 2019 Aug 22. doi: 10.1007/s00406-019-01058-1. [Epub ahead of print]

Mörkl S, Seltenreich D, Letmaier M, Bengesser S, Wurm W, Grohmann R, Bleich S, Toto S, Stübner S, Butler MI, Kasper S.

Extrapyramidal reactions following treatment with antidepressants: Results of the AMSP multinational drug surveillance program.

World J Biol Psychiatry. 2019 Jul 26:1-22. doi: 10.1080/15622975.2019.1648871. [Epub ahead of print]

Toto S, Grohmann R, Bleich S, Frieling H, Maier HB, Greil W, Cordes J, Schmidt-Kraepelin C, Kasper S, Stübner S, Degner D, Druschky K, Zindler T, Neyazi A.

Psychopharmacological Treatment of Schizophrenia over time in 30,908 inpatients - Data from the AMSP study.

Int J Neuropsychopharmacol 2019 Jul 1. pii: pyz037. doi: 10.1093/ijnp/pyz037. [Epub ahead of print]

Greil W, Zhang X, Stassen H, Grohmann R, Bridler R, Hasler G, Toto S, Bleich S, Kasper S.

Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.

Eur Neuropsychopharmacol. 2019 Jan;29(1):111-121.

Schneider M, Regente J, Greiner T, Lensky S, Bleich S, Toto S, Grohmann R, Stübner S, Heinze M.

Neuroleptic malignant syndrome: evaluation of drug safety data from the AMSP program during 1993-2015.

Eur Arch Psychiatry Clin Neurosci. 2018 Nov 30. doi: 10.1007/s00406-018-0959-2. [Epub ahead of print]

Druschky K, Bleich S, Grohmann R, Burda K, Frieling H, Hillemacher T, Neyazi A, Stübner S, Toto S.

Severe hair loss associated with psychotropic drugs in psychiatric inpatients-Data from an observational pharmacovigilance program in German-speaking countries.

Eur Psychiatry. 2018 Oct;54:117-123.

Druschky K, Bleich S, Grohmann R, Engel RR, Neyazi A, Stübner S, Toto S.

Seizure rates under treatment with antipsychotic drugs: Data from the AMSP project.

World J Biol Psychiatry. 2018 Oct 15:1-10.

Greiner T, Schneider M, Regente J, Toto S, Bleich S, Grohmann R, Heinze M.

Priapism induced by various Psychotropics: A Case Series.

World J Biol Psychiatry. 2018 Sep 13:1-17.

Stübner S, Grohmann R, Greil W, Zhang X, Müller-Oerlinghausen B, Bleich S, Rüther E, Möller HJ, Engel R, Falkai P, Toto S, Kasper S, Neyazi A.

Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project.

Int J Neuropsychopharmacol. 2018 Sep 1;21(9):814-821.

Stübner S, Eckermann G, Hiemke C, Lorenzi S; additional authors: Groß G, Rüther E, Bleich S, Toto S.

Psychotropic drugs in palliative care. Practice worthy of discussion

German Medical Journal, May 4, 2018, Issue 18, Vol.115

Letmaier M, Grohmann R, Kren C, Toto S, Bleich S, Engel R, Gary T, Papageorgiou K, Konstantinidis A, Holl AK, Painold A, Kasper S.

Venous thromboembolism during treatment with antipsychotics: Results of a drug surveillance program.

World J Biol Psychiatry. 2018 Apr;19(3):175-186.

Druschky K, Bleich S, Grohmann R, Engel RR, Kleimann A, Stübner S, Greil W, Toto S.

Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.

Eur Arch Psychiatry Clin Neurosci. 2018 Mar;268(2):191-208.

Sanader B, Grohmann R, Grötsch P, Schumann T, Toto S, Fernando P, Stübner S.

Clozapine-Induced DRESS Syndrome: A Case Series From the AMSP Multicenter Drug Safety Surveillance Project.

Pharmacopsychiatry. 2018 Mar 19.

Maier H, Helm S, Toto S, Moschny N, Sperling W, Hillemacher T, Kahl KG, Jakubovski E, Bleich S, Frieling H, Neyazi A.

S100B, Homocysteine, Vitamin B12, Folic Acid, and Procalcitonin Serum Levels in Remitters to Electroconvulsive Therapy: A Pilot Study.

Dis Markers. 2018 Jan 10;2018:2358451.

Ladwig J, Andreae D, Grohmann R, Toto S, Kropp S, Bleich S.

New Onset of Suicidal Impulses Following Abrupt Cessation of Valproate.

Pharmacopsychiatry. 2017 Nov;50(6):270.

Friedrich ME, Akimova E, Huf W, Konstantinidis A, Papageorgiou K, Winkler D, Toto S, Greil W, Grohmann R, Kasper S.

Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program.

Int J Neuropsychopharmacol. 2016 Apr 20;19(4). pii: pyv126.

Kleimann A, Schrader V, Stübner S, Greil W, Kahl KG, Bleich S, Grohmann R, Frieling H, Toto S.

Psychopharmacological treatment of 1650 in-patients with acute mania-data from the AMSP study.

J Affect Disord. 2016 Feb;191:164-71.

Bridler R, Häberle A, Müller ST, Cattapan K, Grohmann R, Toto S, Kasper S, Greil W.

Psychopharmacological treatment of 2195 in-patients with borderline personality disorder: A comparison with other psychiatric disorders.

Eur Neuropsychopharmacol. 2015 Jun;25(6):763-72.

Holl AK, Grohmann R, Letmaier M, Painold A, Mörkl S, Toto S, Kasper S.

Pharmacotherapy of anxiety disorders in German-speaking countries: current status and changes between 1994 and 2011.

Eur Arch Psychiatry Clin Neurosci. 2015 Apr;265(3):199-208.

Spindelegger CJ, Papageorgiou K, Grohmann R, Engel R, Greil W, Konstantinidis A, Agelink MW, Bleich S, Ruether E, Toto S, Kasper S.

Cardiovascular adverse reactions during antidepressant treatment: a drug surveillance report of German-speaking countries between 1993 and 2010.

Int J Neuropsychopharmacol. 2014 Oct 31;18(4).

Kleimann A, Toto S, Eberlein CK, Kielstein JT, Bleich S, Frieling H, Sieberer M.

Psychiatric symptoms in patients with Shiga toxin-producing E. coli O104:H4 induced haemolytic-uraemic syndrome.

PLoS One. 2014 Jul 9;9(7):e101839.

Regular articles in the "Drug Safety/AMSP" section of the journal "Psychopharmacotherapy" (PPT):

Seifert J, Bleich S, Degner D, Rüther E, Grohmann R, Toto S.

Post-injection syndrome after the administration of olanzapine pamoate-

Case report from the project "Drug safety in psychiatry" e. V.

Psychopharmacotherapy 2020;27:25-8.

Seifert J, Bleich S, Degner D, Rüther E, Grohmann R, Toto S.

Persistent genital arousal disorder after discontinuation of sertraline: Case report from the project "Drug Safety in Psychiatry" e. V.

Psychopharmacotherapy 2020;27:77-80.

Reker D, Schneider M, Greiner T, Degner D, Toto S, Bleich S, Grohmann R, Heinze M.

Craving under mirtazapine

Psychopharmakotherapie 2019;26:156-60.

Schneider M, Greiner T, Degner D, Bleich S , Grohmann R, Toto S, Heinze M.

Urinary retention during combination therapy with mirtazapine, risperidone and solifenacin

Psychopharmakotherapie 2019;26:299–302.

Schneider M, Greiner T, Heinze M, Degner D, Grohmann R, Toto S.

Bleeding tendency under escitalopram

Psychopharmacotherapy 2018;25:36-9.

Greiner T, Schneider M, Degner D, Toto S, Stefan Bleich S, Grohmann R, Heinze M.

Myoclonias under polypharmacy

Psychopharmakotherapie 2018;25:208-10.

Papalampros G, Andreae D, Kropp S, Degner D, Grohmann R, Toto S.

Severe dysphagia under risperidone. Adverse drug reactions when used in geriatric psychiatry

Psychopharmakotherapie 2017;24:69-72.

Thume K, Kindler C, Reiff J, Braus DF, Grohmann R, Degner D, Toto S.

Serotonergic ADRs under duloxetine and tramadol with unexpected duloxetine level elevation

Psychopharmakotherapie 2017;24:172-4.

Krummenauer F, Bschor T, Valle E, Degner D, Grohmann R , Toto S.

Respiratory insufficiency with coma after lorazepam ingestion

Psychopharmakotherapie 2017;24:283-5.

Burda K, Degner D, Grohmann R, Bavendiek U, Toto S.

Myocarditis under clozapine

Psychopharmacotherapy 2016;23:254-7.

Haas I, Schumacher B, Rüther E, Grohmann R, Toto S, Degner D.

Syncope under prothipendyl

Psychopharmacotherapy 2016;23:165-9.

Dabbert D, Zimmermann J, Toto S, Grohmann R.

I-dystonic suicidal thoughts-after discontinuation of a 3-day sertraline administration

Psychopharmakotherapie 2015;22:212-3.

Dabbert D, Mauer A, Fuchs T, Grohmann R, Toto S, Rüther E, Degner D.

Maculopapular exanthema as an allergic reaction to quetiapine

Psychopharmacotherapy 2014;21:72-4.

Baumgärtner J , Eckermann G, Grohmann R, Schmauß M, Toto S, Stübner S.

Sedation under combination treatment - adverse drug reaction as a reason for admission

Psychopharmakotherapie 2014;21:118-22.